Forum on anabolic steroids brings together specialist doctors and health professionals |

With the support of its Technical Chambers of Urology, Sports Medicine, and Endocrinology and Metabolism, the Federal Council of Medicine (CFM) held this Tuesday (3), the 1st Forum on the Use of Anabolic Androgenic Steroids of the CFM. The activity aims to discuss different aspects related to these substances with the aim of defining proposals to control excess prescription or misuse.

At the opening table of the event, federal counselor Annelise Meneguesso (coordinator of the Technical Chamber of Endocrinology and Metabology) highlighted the first anniversary of CFM Resolution No. 2,333/23, which vetoes hormonal therapies for aesthetic and sports performance purposes, is about to complete a year of its publication.

“Over the last year, we have observed changes in the behavior of prescribing doctors and the population in relation to awareness of the risks they were exposed to due to bad practice. [de prescrição e utilização de esteroides androgênicos anabolizantes sem evidências clínico-científicas]. But we still have a long way to go before we reach the full protection of society and this forum is an important step in that direction,” he said.

Forum – For federal councilor Luís Guilherme Teixeira dos Santos, coordinator of the Technical Chamber of Urology, “today, after a lot of struggle, we have the best forum, which is the CFM, for technical, legal and legal discussion on the prescription of hormonal therapies with androgenic steroids and anabolic steroids, bringing science and what we have exactly to our patients.” According to him, the CFM has broken paradigms to bring medical specialty societies and other health professionals to the debate around the topic.

The 1st vice-president of the CFM, Jeancarlo Cavalcante, also points to CFM Resolution nº 2,333/23 as a historic milestone in relation to the role of the Federal Council of Medicine, as a regulatory authority. He expressed the desire for a productive discussion and the expectation that “the group can emerge stronger in relation to decisions that directly affect the Brazilian population”.

Themes – In the morning stage, topics such as the use of testosterone replacement therapy in patients with obesity were discussed (presented by Rodrigo de Oliveira Moreira, from the Brazilian Society of Endocrinology and Metabology); androgenic disorder of male aging (presented by Rodrigo Barros de Castro, from the Brazilian Society of Urology); And Hypoactive Sexual Desire Syndrome (addressed by Maria Celeste Osório Wender, president of the Brazilian Federation of Gynecology and Obstetrics Associations – Febrasgo).

The adverse effects of the use of anabolic steroids were also addressed. Specialist doctors from the Brazilian Society of Endocrinology and Metabology (Clayton Luiz Dornelles Macedo), the Brazilian Society of Urology (Leonardo Seligra Lopes) and the Association for the Study of Obesity and Metabolic Syndrome (Adriano Segal), among others, presented and discussed various side effects in the cardiovascular (such as high blood pressure, increased visceral adiposity, arrhythmias), hepatic (increased liver enzymes, toxic steatosis, liver neoplasia), and infectious (such as viral hepatitis, abscesses, systemic infections and sepsis) scope, etc.

Another prominent topic was doping in high performance. Participating were Adriana Taboza de Oliveira, president of the Brazilian Doping Control Authority (ABCD), who spoke about the anti-doping movement and the role of ABCD and the World Anti-Doping Agency (WADA) in editing the List of Substances and Prohibited Methods.

Taboza advocates that doctors be aware of these substances that cause potential or actual gains in sporting performance, that pose a real or potential risk to the athlete’s health and that violate the spirit of sport. On the topic, José Kawazoe Lazzoli, president of the ABCD Therapeutic Use Authorization Committee, spoke about anti-doping control and authorization for the therapeutic use of substances.

Follow the afternoon stage live on YouTube: